NASDAQ: AXDX - Accelerate Diagnostics, Inc.

Rentabilidade por seis meses: -71.74%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Accelerate Diagnostics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.

mais detalhes
It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 1996-11-18
ISIN US00430H1023
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://acceleratediagnostics.com
Цена ао 0.8771
Alteração de preço por dia: -1.65% (0.546)
Alteração de preço por semana: -7.46% (0.5803)
Alteração de preço por mês: -53.3% (1.15)
Alteração de preço em 3 meses: -50.28% (1.08)
Mudança de preço em seis meses: -71.74% (1.9)
Mudança de preço por ano: -40.99% (0.91)
Mudança de preço em 3 anos: -51.18% (1.1)
Mudança de preço em 5 anos: -93.88% (8.77)
Mudança de preço desde o início do ano: -54.87% (1.19)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.29 6
P/BV -0.4782 0
P/E 0 0
EV/EBITDA -2.13 0
Total: 4.5

Eficiência

Nome Significado Nota
ROA, % -167.03 0
ROE, % 131.82 10
Total: 3.33

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -1.79 10
Total: 9.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 4.45 1
Rentabilidade Ebitda, % -41.05 0
Rentabilidade EPS, % -84.62 0
Total: 0.2
Mais detalhes

Instituições Volume Compartilhar, %
Griffin Asset Management, Inc. 1219724 5.63
Vanguard Group Inc 306637 1.42
Birchview Capital, LP 225239 1.04
Cannell (Peter B.) & Company Inc 114690 0.53
Oracle Investment Management Inc 111575 0.52
Geode Capital Management, LLC 87003 0.4
Chartist, Inc. 68996 0.32
TCI Wealth Advisors, Inc. 58680 0.27
Blackrock Inc. 50842 0.23
Northern Trust Corporation 46119 0.21



Supervisor Cargo Pagamento Ano de nascimento
Mr. Jack Phillips CEO, President & Director 595k 1966 (59 anos)
Mr. Lawrence Michael Mertz Chief Technology Officer 335.94k 1963 (62 ano)
Mr. David Patience Chief Financial Officer 285.27k 1986 (39 anos)
Ms. Maya Gowri Senior VP & Head of Operations N/A
Laura Pierson Investor Relations Officer N/A
Mr. John Meduri Chief Strategy Officer N/A
Mr. Chris Thode Senior Vice President of US Commercial N/A
Ms. Rita Boukamel Senior VP & Head of EMEA N/A

Endereço: United States, Tucson. AZ, 3950 South Country Club Road - abrir no Google Maps, abrir mapas Yandex
Site: https://acceleratediagnostics.com